These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. The Changing Face of Synthetic Cannabinoids in Texas. Maxwell JC J Psychoactive Drugs; 2018; 50(4):281-286. PubMed ID: 30321129 [TBL] [Abstract][Full Text] [Related]
63. Clinical features associated with ADB-BUTINACA exposure in patients attending emergency departments in England. King A; Hill SL; Pucci M; Bailey G; Keating L; Macfarlane R; Cantle F; Hudson S; Thomas SHL Clin Toxicol (Phila); 2022 Oct; 60(10):1094-1098. PubMed ID: 35943421 [TBL] [Abstract][Full Text] [Related]
64. First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201. McQuade D; Hudson S; Dargan PI; Wood DM Eur J Clin Pharmacol; 2013 Mar; 69(3):373-6. PubMed ID: 22936123 [TBL] [Abstract][Full Text] [Related]
66. Psychiatric correlates of past incarceration in the national co-morbidity study replication. Greenberg GA; Rosenheck RA Crim Behav Ment Health; 2014 Feb; 24(1):18-35. PubMed ID: 23881907 [TBL] [Abstract][Full Text] [Related]
67. Forensic and nonforensic clients in assertive community treatment: a longitudinal study. Beach C; Dykema LR; Appelbaum PS; Deng L; Leckman-Westin E; Manuel JI; McReynolds L; Finnerty MT Psychiatr Serv; 2013 May; 64(5):437-44. PubMed ID: 23370489 [TBL] [Abstract][Full Text] [Related]
68. Vaping cannabis among adolescents: prevalence and associations with tobacco use from a cross-sectional study in the USA. Kowitt SD; Osman A; Meernik C; Zarkin GA; Ranney LM; Martin J; Heck C; Goldstein AO BMJ Open; 2019 Jun; 9(6):e028535. PubMed ID: 31196904 [TBL] [Abstract][Full Text] [Related]
69. Shape matters: The application of activity-based in vitro bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug-infused papers seized in prisons. Antonides LH; Cannaert A; Norman C; NicDáeid N; Sutcliffe OB; Stove CP; McKenzie C Drug Test Anal; 2021 Mar; 13(3):628-643. PubMed ID: 33161649 [TBL] [Abstract][Full Text] [Related]
70. The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users. Shapira B; Rosca P; Berkovitz R; Gorjaltsan I; Neumark Y PeerJ; 2020; 8():e9461. PubMed ID: 32742781 [TBL] [Abstract][Full Text] [Related]
71. Concurrent Disorders and Health Care Utilization Among Homeless and Vulnerably Housed Persons in Canada. Zhang L; Norena M; Gadermann A; Hubley A; Russell L; Aubry T; To MJ; Farrell S; Hwang S; Palepu A J Dual Diagn; 2018; 14(1):21-31. PubMed ID: 29494795 [TBL] [Abstract][Full Text] [Related]
72. Factors associated with chronic pain and non-medical opioid use among people who inject drugs. Bicket MC; Park JN; Torrie A; Allen ST; Weir BW; Sherman SG Addict Behav; 2020 Mar; 102():106172. PubMed ID: 31704433 [TBL] [Abstract][Full Text] [Related]
73. Synthetic drugs of abuse. Tamama K Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850 [TBL] [Abstract][Full Text] [Related]
74. Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana. Clayton HB; Lowry R; Ashley C; Wolkin A; Grant AM Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28289138 [TBL] [Abstract][Full Text] [Related]
75. Prescription Opioid Misuse and Use of Alcohol and Other Substances Among High School Students - Youth Risk Behavior Survey, United States, 2019. Jones CM; Clayton HB; Deputy NP; Roehler DR; Ko JY; Esser MB; Brookmeyer KA; Hertz MF MMWR Suppl; 2020 Aug; 69(1):38-46. PubMed ID: 32817608 [TBL] [Abstract][Full Text] [Related]
76. Prevalence of cathinones and other new psychoactive substances in hair of parents and children of families with known or suspected parental abuse of conventional illegal drugs. Niebel A; Pragst F; Krumbiegel F; Hartwig S Forensic Sci Int; 2022 Feb; 331():111148. PubMed ID: 34923263 [TBL] [Abstract][Full Text] [Related]
77. Food Insecurity, Morbidities, and Substance Use in Adults on Probation in Rhode Island. Dong KR; Must A; Tang AM; Stopka TJ; Beckwith CG J Urban Health; 2018 Aug; 95(4):564-575. PubMed ID: 30030685 [TBL] [Abstract][Full Text] [Related]
78. Why Switch? - Motivations for Self-Substitution of Illegal Drugs. Shapira B; Berkovitz R; Rosca P; Lev-Ran S; Kaptsan A; Neumark Y Subst Use Misuse; 2021; 56(5):627-638. PubMed ID: 33663337 [TBL] [Abstract][Full Text] [Related]
79. Cross-Sectional Association Between Lifetime Use of Electronic Cigarettes With or Without Marijuana and Self-Reported Past 12-Month Respiratory Symptoms as well as Lifetime Respiratory Diseases in U.S. Adults. Xie Z; Li D Nicotine Tob Res; 2020 Dec; 22(Suppl 1):S70-S75. PubMed ID: 33320251 [TBL] [Abstract][Full Text] [Related]